Early Access — free while we kick the tires
EdgarHawk

BASKETT FOREST

10% Owner

10% Owner
3 filings analyzed · 3 companies · Latest 2026-03-12

Companies

Company Buys Sells Direction
Korro Bio, Inc. KRRO 1 0 Net buying
SpyGlass Pharma, Inc. SGP 7 0 Net buying
MBX Biosciences, Inc. MBX 3 0 Net buying

Activity

March 2026
2026-03-12 Korro Bio, Inc. KRRO
high
Buy
207,100 shares
$2,300,881
Significance 6/10

10% owner Baskett Forest buys 207,100 shares of KRRO at $11.11; 8 other insiders bought in past 14 days amid -77.6% decline from 52-week high.

Baskett Forest, a 10% shareholder, purchased 207,100 shares for $2,300,881.00 on 2026-03-10 at $11.11, expanding holdings by 19.0% to 1,297,893 shares. This purchase occurs within a concentrated cluster: 8 other insiders also bought within the past 14 days, suggesting coordinated confidence among the insider group. However, context is mixed: the stock trades at $11.50 currently, down 77.6% from its 52-week high of $51.36, and Forest's prior KRRO purchase on 2024-04-22 saw a 90-day return of -18.6%, showing previous misjudgment at this ticker. The company reported revenue of $1,090,000.00 in its latest quarter with a net loss of -$18,061,000.00, though annual revenue growth reached +181.5%, indicating early-stage or transition-phase fundamentals. The cluster buying pattern and insider accumulation merit attention, but the severe price decline and unprofitable operations introduce material uncertainty about the conviction underlying the purchase.

February 2026
high
Buy
937,500 shares
$15,000,000
Significance 8/10

10% Owner Baskett Forest bought 937,500 shares of SGP at $16.00 for $15.0M on 2026-02-09; current price $27.55.

Baskett Forest, a 10% shareholder, purchased 937,500 shares at $16.00 for a total value of $15,000,000.00, increasing holdings from 419,763 shares to 1,357,263 shares—a +223.3% increase in pre-transaction holdings. The stock has appreciated 72% since the purchase (trading at $27.55 as of 2026-02-11), four trading days after the transaction. Notably, 14 other insiders also bought within the past 14 days, establishing a cluster buy pattern that suggests broad insider conviction across multiple stakeholders. The derivative-conversion nature of this filing indicates the insider's position also includes unconverted securities not yet reflected in Table I, so the reported post-transaction holdings represent a partial view of total economic exposure.

September 2024
high
Buy
500,000 shares
$8,000,000
Significance 7/10

10% owner Baskett Forest buys 500,000 MBX shares at $16.00 ($8.0M) amid cluster of 14 insiders buying in 14 days

BASKETT FOREST, a 10% owner, purchased 500,000 shares of MBX Biosciences at $16.00 on 2024-09-16, increasing his post-transaction holdings to 3,614,486 shares. This $8,000,000 acquisition occurs just 3 trading days after MBX's recent listing and is part of a notable cluster pattern: 14 other insiders also bought within the past 14 days. The stock is currently trading at $21.50, representing a gain of $2,750,000 on this transaction since execution. The concurrent buying activity by multiple insiders at near-listing prices suggests shared conviction about the company's near-term prospects, though the brief post-IPO window limits historical context for assessing insider decision quality at this security.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access